Cramer's Take on Ligand Pharmaceuticals Incorporated Class(LGND)
No results found.
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,297.23 | 1,093.37 | 2,171.91 | 33.79 |
Oil *
75.41
|
|
DOWN
92.88
|
DOWN
9.88
|
DOWN
17.70
|
DOWN
0.69
|
10 Yr
3.38%
SPDR Gold
112.33
|
|
-0.89%
|
-0.90%
|
-0.81%
|
-2.00%
|
Data delayed 20 minutes |
More From TheStreet
Latest Headlines
Brokerage Partners
Resources
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS: Now any level of investor can trade right alongside a Wall Street pro — and enjoy 24/7 access to his portfolio! Learn More
NEW! Don Dion's ETF Action: A concise two-step strategy for learning and trading in this increasingly lucrative area of investing. For all levels of investors! Learn More
RealMoney: Jim Cramer's team of 70+ investment pros offer a daily wealth of fast-breaking market news... analyses... red-hot opportunities...and wealth-building strategies. Learn More
RealMoney Silver: The genius of Doug Kass + 5 Premium Services = an unrivaled group of expert fundamental analysts, technical analysts, and Wall Street observers. Learn More
Breakout Stocks: Bryan Ashenberg combines sophisticated screening software with eagle-eye analysis to find small and mid-caps ready to break out! Learn More
We respect your privacy.
Podcasts
Connect with TheStreet